110 related articles for article (PubMed ID: 7330795)
1. Serum, saliva, and sputum levels of metronidazole in acute exacerbations of chronic bronchitis.
Siegler D; Kaye CM; Reilly S; Willis AT; Sankey MG
Thorax; 1981 Oct; 36(10):781-3. PubMed ID: 7330795
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin in acute exacerbations of chronic bronchitis.
Hoogkamp-Korstanje JA; Klein SJ
J Antimicrob Chemother; 1986 Sep; 18(3):407-13. PubMed ID: 3490468
[TBL] [Abstract][Full Text] [Related]
3. Serum, sputum and bronchial concentrations of erythromycin in chronic bronchitis after single and multiple treatments with either propionate-N-acetylcysteinate or stearate erythromycin.
Ricevuti G; Pasotti D; Mazzone A; Gazzani G; Fregnan GB
Chemotherapy; 1988; 34(5):374-9. PubMed ID: 3180905
[TBL] [Abstract][Full Text] [Related]
4. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
[TBL] [Abstract][Full Text] [Related]
5. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB
Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508
[TBL] [Abstract][Full Text] [Related]
6. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.
Davies BI; Maesen FP; Teengs JP
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():83-9. PubMed ID: 6594325
[TBL] [Abstract][Full Text] [Related]
7. Erythromycin succinate in the treatment of acute exacerbations of chronic bronchitis.
Beumer HM; Dubourg AY; Soetens A
Eur J Clin Pharmacol; 1978 Mar; 13(1):25-7. PubMed ID: 346354
[TBL] [Abstract][Full Text] [Related]
8. Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis.
Woolhouse IS; Hill SL; Stockley RA
Thorax; 2001 Dec; 56(12):947-53. PubMed ID: 11713358
[TBL] [Abstract][Full Text] [Related]
9. Sputum and blood concentrations of cefuroxime in lower respiratory tract infection.
Havard CW; Bax RP; Samanta TC; Pearson RM; Brumfitt W; Hamilton-Miller JM; Dash CH
Thorax; 1980 May; 35(5):379-83. PubMed ID: 7434289
[TBL] [Abstract][Full Text] [Related]
10. [Histamine content of the sputum of patients with obstructive bronchitis].
Zimmermann I; Bugalho de Almeida AA; Ulmer WT
Respiration; 1987; 51(1):10-5. PubMed ID: 3563119
[TBL] [Abstract][Full Text] [Related]
11. Erythromycin and bromhexine in acute exacerbations of chronic bronchitis. A study on sputum penetration and clinical effectiveness.
Maesen FP; Davies BI; Brouwers J; Rubingh G
Eur J Respir Dis; 1982 Jul; 63(4):325-9. PubMed ID: 6981522
[TBL] [Abstract][Full Text] [Related]
12. Sputum and plasma doxycycline concentrations after a single oral 600 mg doxycycline dose in patients with chronic bronchitis.
Marlin GE; Cheng S; Thompson PJ
Eur J Respir Dis; 1981 Aug; 62(4):276-80. PubMed ID: 7308339
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of elastase and alpha1-antitrypsin in sputum of asthmatic patients.
Vignola AM; Bonanno A; Mirabella A; Riccobono L; Mirabella F; Profita M; Bellia V; Bousquet J; Bonsignore G
Am J Respir Crit Care Med; 1998 Feb; 157(2):505-11. PubMed ID: 9476865
[TBL] [Abstract][Full Text] [Related]
14. Effect of atropine on sputum production.
Lopez-Vidriero MT; Costello J; Clark TJ; Das I; Keal EE; Reid L
Thorax; 1975 Oct; 30(5):543-7. PubMed ID: 1198394
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline in serum and bronchial secretions.
Hartnett BJ; Marlin GE
Thorax; 1976 Apr; 31(2):144-8. PubMed ID: 821169
[TBL] [Abstract][Full Text] [Related]
16. Serum and sputum levels of cefaclor.
Simon C; Gatzemeier U
Postgrad Med J; 1979; 55 Suppl 4():30-4. PubMed ID: 548940
[TBL] [Abstract][Full Text] [Related]
17. Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
Maesen FP; Davies BI; van den Bergh JJ; Gubbelmans HL; Meek JC; Geraedts WH
J Antimicrob Chemother; 1990 Mar; 25(3):413-22. PubMed ID: 2187013
[TBL] [Abstract][Full Text] [Related]
18. Effective monitoring of concentrations of ofloxacin in saliva of patients with chronic respiratory tract infections.
Koizumi F; Ohnishi A; Takemura H; Okubo S; Kagami T; Tanaka T
Antimicrob Agents Chemother; 1994 May; 38(5):1140-3. PubMed ID: 8067752
[TBL] [Abstract][Full Text] [Related]
19. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
Paster RZ; McAdoo MA; Keyserling CH; Nemeth MA; Tack KJ; Griffin TJ
Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
[TBL] [Abstract][Full Text] [Related]
20. Airway mucosal permeability in chronic bronchitics and bronchial asthmatics with hypersecretion.
Honda I; Shimura S; Sasaki T; Sasaki H; Takishima T; Nakamura M
Am Rev Respir Dis; 1988 Apr; 137(4):866-71. PubMed ID: 3354993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
